This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.

Confident Diagnosis in Seconds

AI-powered clinical decision support for radiologists. Transform your practice with Smart Ultrasound® technology that improves accuracy, reduces false positives, and enhances workflow efficiency.

Koios DS Breast Software Interface
101+
Installation Sites
28
Countries
2M+
Images Trained
35-40%
Fewer Benign Biopsies

Smart Ultrasound® Software

FDA-Cleared • CE Marked • Billable Procedure
AI-powered tools for breast and thyroid cancer diagnosis that improve survival rates and workflow efficiency.

Koios DS Breast

Koios DS™ Breast

AI-powered clinical decision support for breast cancer diagnosis using ultrasound imaging. Analyzes over 17,900 features per image to provide accurate risk assessment.

  • • FDA 510(k) Cleared
  • • CE Marked
  • • Reduces unnecessary biopsies by 35-40%
  • • Billable CPT code available
Learn More
Koios DS Thyroid

Koios DS™ Thyroid

Advanced AI assistance for thyroid nodule classification. Helps radiologists make faster, more confident decisions with reduced variability.

  • • FDA 510(k) Cleared
  • • CE Marked
  • • Supports TI-RADS assessment
  • • Integrates with PACS and EMR
Learn More
Smart Ultrasound Demo

Smart Ultrasound® Platform

End-to-end AI platform built on an ensemble of deep learning algorithms trained on a proprietary dataset of over 2 million ultrasound images.

  • • Ensemble AI model
  • • 17.9k features analyzed per image
  • • Cloud or on-premise deployment
  • • Real-time analysis in seconds
Learn More
Clinical Integration

Seamless Integration

Designed to integrate smoothly into existing clinical workflows. Compatible with leading ultrasound systems and hospital IT infrastructure.

  • • DICOM compatible
  • • HL7 & FHIR support
  • • Works with major PACS vendors
  • • Secure cloud architecture
Learn More
Cancer Detection Accuracy

High Cancer Detection Rate

Proven performance in detecting invasive lobular carcinoma and other subtle cancers that are often missed in conventional ultrasound.

  • • Perfect performance in ILC studies
  • • Retrospective review validated
  • • Increases early detection
  • • Reduces human error
Learn More
Workflow Efficiency

Workflow Optimization

Reduces interpretation time by up to 49%, allowing radiologists to see 25+ additional patients per day without compromising accuracy.

  • • 49% less interpretation time
  • • 40% fewer follow-ups
  • • Faster report turnaround
  • • Improved patient throughput
Learn More
Global Deployment

Global Clinical Adoption

Trusted in 28 countries across 6 continents. Over 101 active installations with 1-2 new sites going live weekly.

  • • 28 countries
  • • 101+ installations
  • • 1-2 new sites/week
  • • Multi-language support
Learn More
ROI and Cost Savings

Proven ROI & Cost Savings

Delivers 50-109x return on investment to payers by reducing unnecessary procedures, treatment spend, and patient out-of-pocket costs.

  • • 50-109x ROI to payer
  • • Millions saved in treatment
  • • Reduces false positives
  • • Prevents over-treatment
Learn More

Koios DS: Software with Vision

Cancer diagnosis with ultrasound requires great vision. Koios software uses artificial intelligence and machine learning to provide clinical decision support (“DS”) for physicians and technologists. We call it Smart Ultrasound™.

Our AI models are trained on a proprietary dataset of over 2 million ultrasound images, analyzing 17,900 features per image to deliver accurate, real-time cancer risk assessments.

FDA Cleared FDA 510(k) Cleared CE Marked CE Marked
Koios DS Software Interface

Research Highlights

Peer-reviewed studies and clinical validations demonstrating the impact of Koios AI in cancer detection.

August 14, 2023

Koios AI Shows Perfect Performance in Invasive Lobular Carcinoma

A new retrospective review shows our AI-powered cancer recognition software can make diagnosing invasive lobular carcinomas significantly easier, with perfect sensitivity in test cases.

Read More →
July 21, 2023

Doctors TOUT Use of AI to Detect Breast Cancer

Radiologists across the U.S. report increased diagnostic confidence and reduced workload after integrating Koios DS into their daily practice.

Read More →
February 28, 2023

Mitsui & Co. Invests in Koios Medical

Global trading and investment company Mitsui & Co., Ltd. has participated in a strategic investment round to accelerate Koios Medical’s global expansion and R&D initiatives.

Read More →
Ongoing

Clinical Studies & Patent Portfolio

Koios DS has multiple U.S. and international patents granted, including U.S. Pat. Nos. 9,536,054; 9,934,567; 10,339,650; and more. Additional clinical studies are ongoing to broaden indications.

View Patents →

Trusted by Leading Radiologists

Real-world impact from clinicians using Koios DS every day.

“A great example... a second lesion had really benign features, but I was surprised when I ran Koios it was a BI-RADS 4. We biopsied the lesion and it was cancer.”

Dr. Bobbi Ring
Co-Section Chief, Main Street Radiology / NY Presbyterian
1,000+ Cases Analyzed

“[Koios] just provides that precision diagnostic accuracy... to ensure we're doing the best for patients. It's very amazing because these seconds add up to minutes, minutes to hours. We see value in that.”

Dr. Amy Patel
Associate Professor, Director of Women's Imaging at Liberty Hospital
500+ Cases Analyzed

“You're recommending less biopsies for things that are really benign and not recommending short-term follow-ups… Those are significant changes in a practice. When I can save a six-month follow-up, it's very useful.”

Dr. Lai Ming Yu
Breast Radiologist, Main Street Radiology / NY Presbyterian
1,400+ Cases Analyzed

Get in Touch

Ready to transform your radiology practice with AI-powered decision support?

Visit Official Website to Contact

Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.

For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact support@fobcompany.info via your corporate email to cancel. We will cancel your inclusion within 3 business days.

如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系support@fobcompany.info 取消收录 我们将在3个工作日取消您的收录

Service Request: If you are other domain and want to be included, please contact support@fobcompany.info

如果您是其他域名合作 也请联系support@fobcompany.info